Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
---|
08/15/2000 | US6103730 Amine substituted compounds |
08/15/2000 | CA2202280C Sugar modified nucleosides and their use for synthesis of oligonucleotides |
08/10/2000 | WO2000045635A1 Thiazole derivatives and combinatorial libraries thereof |
08/09/2000 | EP1025103A1 Novel polymorphic forms of cipamfylline |
08/09/2000 | CN1262273A Process for preparing guanine by pressing |
08/08/2000 | US6100404 Erythromycin compounds |
08/08/2000 | US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents |
08/08/2000 | US6100270 Bicyclic heterocyclic compounds for the treatment of impotence |
08/08/2000 | CA2017066C Azaindenes |
08/03/2000 | WO2000044750A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND Iλ-A$g(a) |
08/03/2000 | WO2000020421A3 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS |
08/03/2000 | CA2361518A1 Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha. |
08/02/2000 | EP1023316A2 Methods and compositions for lipidization of hydrophilic molecules |
08/02/2000 | EP1023292A1 Process for the synthesis of chloropurine intermediates |
08/01/2000 | US6096724 O(6)-alkylguanine-dna alkyltransferase (atase) enzyme inhibitors |
07/27/2000 | WO2000043394A1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof |
07/27/2000 | WO2000042989A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
07/27/2000 | WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses |
07/27/2000 | WO1999063994A9 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
07/26/2000 | EP1021429A1 Aryl furan derivatives as pde iv inhibitors |
07/26/2000 | EP1021186A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha |
07/25/2000 | US6093819 Reacting guanine with a chlorinating agent in the presence of methyltriethylammonium chloride to form 2-amino-6chloropurine then substituting at 9-position with appropriate side chain, followed by hydrolysis or reduction of 6-chloro moiety |
07/25/2000 | US6093703 Pharmaceutical compositions, containing S-adenosyl-L-methionine salt, 5-methyl-tetrahydrofolic acid and 5-formyltetrahydrofolic acid |
07/25/2000 | CA2141029C Stereoselective synthesis of nucleoside analogues using bicyclic intermediate |
07/20/2000 | WO2000041708A1 Composition for treating obesity and aesthetic treatment method |
07/20/2000 | WO2000041474A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
07/20/2000 | CA2359365A1 Anti-cd3 immunotoxins and therapeutic uses therefor |
07/20/2000 | CA2323711A1 Composition for treating obesity and aesthetic treatment method |
07/19/2000 | EP1019426A1 Novel a 1? adenosine receptor agonists and antagonists |
07/19/2000 | EP1019404A1 Purine acyclonucleosides as antiviral agents |
07/19/2000 | EP1019403A1 Process for preparing purine derivatives |
07/19/2000 | EP1019056A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89 |
07/18/2000 | US6090937 Methods for producing nucleoside derivatives and intermediates therefor |
07/18/2000 | US6090816 Antiasthma agents |
07/12/2000 | EP1018514A1 NF-$g(k)B INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT |
07/12/2000 | EP1017394A1 Cyclin dependent kinase inhibiting purine derivatives |
07/11/2000 | US6087501 Hydrolysis of imines to form amides |
07/11/2000 | US6087497 Debenzylation of purine to form viricides |
07/11/2000 | CA2012851C Purinyl and pyrimidinyl tetrahydrofurans |
07/06/2000 | WO2000039751A2 System and method for structure-based drug design that includes accurate prediction of binding free energy |
07/06/2000 | WO2000039143A2 Antiviral nucleoside analogues |
07/05/2000 | EP1015451A1 Tetrahydro gamma-carbolines |
07/05/2000 | EP0563168B1 Xanthine derivatives |
07/04/2000 | US6084095 Including 6-amino-4-(3-bromoanilino)pyrido(3,2-d)pyrimidine; 4-(3-bromoanilino)-6-methylaminopyrido (3,2-d)pyrimidine; and 4-(3-bromoanilino)-6-methylaminopyrido(3,2-d)pyrimidine; useful in treating proliferative diseases such as cancer |
07/04/2000 | US6084082 Solid phase synthesis by attaching beta-lactam having nucleobase to solid support, deprotecting hydroxy group, reacting free hydroxyl group with beta-lactamtide having activated phosphite group, and oxidizing |
07/04/2000 | US6083954 Method of treating cystic fibrosis |
07/04/2000 | US6083953 Treating herpes simplex virus or cytomegalovirus infections; valganciclovir hydrochloride in crystalline form; antiviral; oral administration |
07/04/2000 | US6083483 For the modulation of the motility and peristalsis of the hollow organs of the urogenital and gastrointestinal tract |
07/04/2000 | CA2016142C Sulfonamides |
07/04/2000 | CA1341043C Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents |
06/29/2000 | WO2000037471A1 2-amino-9-alkylpurines: gaba brain receptor ligands |
06/29/2000 | WO2000023447B1 Adenosine analogues having antihypertensive, cardioprotective, anti-ischemic antilipolytic properties |
06/28/2000 | EP1014184A2 Photographic element containing a dir coupler |
06/28/2000 | EP0574386B1 Novel process for the preparation of nucleotides |
06/27/2000 | US6080746 Methods and compositions for the prophylaxis and treatment of cytomegalovirus infections |
06/21/2000 | EP1010700A1 Process for the preparation of guanine under pressure |
06/21/2000 | DE19857949A1 Verfahren zur Herstellung von Guanin unter Druck Process for the preparation of guanine under pressure |
06/20/2000 | CA2013381C Selective adenosine receptor compounds |
06/20/2000 | CA1341034C Heterocyclic 2-alkoxyphenoxysulfonylureas and the use thereof as herbicides or plant growth regulators |
06/15/2000 | WO2000006531A3 Nitric esters and nitrate salts of specific drugs |
06/14/2000 | EP1007042A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction |
06/14/2000 | EP0746326A4 Oligomeric compounds having nitrogen-containing linkages |
06/14/2000 | CN1053435C Method for extracting tea polyphenol and by-products from tea leaves |
06/13/2000 | US6075143 Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids |
06/13/2000 | US6075029 Xanthine modulators of metabolism of cellular P-450 |
06/13/2000 | CA2107014C Therapeutic agent for parkinson's disease |
06/08/2000 | WO2000032197A1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
06/07/2000 | EP1006115A2 Imidazopyridines having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
06/07/2000 | EP1005356A1 Novel antibacterial agents |
06/06/2000 | US6072053 Antiviral compound |
06/06/2000 | US6072051 Viricide against hepatitis b virus with low toxicity |
06/06/2000 | US6071922 Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activities of 1,3-oxaselenolane nucleosides |
06/02/2000 | WO2000031063A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
06/02/2000 | CA2351725A1 Substituted pyrazoles as p38 kinase inhibitors |
05/31/2000 | EP1004593A2 Backbone modified oligonucleotide analogues |
05/31/2000 | EP1003746A1 Purine inhibitor of protein kinases, g proteins and polymerases |
05/31/2000 | EP1003541A1 Inhibitors of hiv reverse transcriptase |
05/31/2000 | CN1255132A Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of 1-3-oxaselenolane nucleosides |
05/31/2000 | CN1052984C New erythromycin derivative and its preparing process and application in medicine |
05/30/2000 | US6069250 Method and compositions for the synthesis of dioxolane nucleosides with β-configuration |
05/30/2000 | CA1341007C Alkyl- and alkenylsulfonylureas which are substituted in the heterocycle, processes for their preparation, and their use as herbicides or plant growth regulators |
05/25/2000 | WO2000016755A3 Antiviral combinations of lamivudine and adefovir |
05/23/2000 | US6066641 Phosphodiesterases as molecular targets for anti-asthmatic agents |
05/17/2000 | EP1000055A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
05/17/2000 | CN1253502A Method of using cyclooxygenase-2 inhibitors in prevention of cardiovascular disorders |
05/16/2000 | US6063569 Methods for automated synthesis of PNA-DNA chimeras and compositions thereof |
05/16/2000 | US6063407 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
05/11/2000 | WO2000025797A1 Combination therapy to treat hepatitis b virus |
05/10/2000 | EP0999211A1 Novel purine derivatives and medicinal use thereof |
05/10/2000 | EP0998480A1 Nucleotide analog composition and synthesis method |
05/10/2000 | EP0741710B1 Chloropyrimidine intermediates |
05/09/2000 | US6060459 Enhancing blood cell count with oxypurine nucleosides |
05/09/2000 | CA2112239C Enantiomeric hydroxylated xanthine compounds |
05/04/2000 | WO1999063988A9 Inhibitors of nitric oxide synthase |
05/03/2000 | EP0996617A1 Novel compounds |
05/03/2000 | CN1252071A Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl) phenyl derivatives, their preparation and use in treatment of inflammatory conditions and immune disorders |
05/02/2000 | US6057445 Formation of carbon nitrogen bond, cyclization and halogenation |
05/02/2000 | US6057334 Benzo[g]quinoline derivatives |
05/02/2000 | US6057327 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections |